Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

“Pure and deadly greed”: Lawmakers slam Pfizer’s 400% price hike on COVID shots

Por: Ars Technica Science December 14, 2022

thumbnail

Navigate Filter by topic Settings Front page layout Site theme - Dec 14, 2022 1:57 pm UTC / Pfizer Chairman and CEO Dr. Albert Bourla speaks onstage at the 2022 SXSW Conference at JW Marriott Austin on March 14, 2022, in Austin. Share this story Senator Elizabeth Warren (D-Mass.) and Senator-elect Peter Welch (D-Vt.) sent to Pfizer CEO Albert Bourla this week over the company's plan to increase the price of its COVID-19 vaccines by 400... + full article



Similar News

Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history

CNBC USA Health December 06, 2022

thumbnailVials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven

MarketWatch USA Business November 26, 2022

thumbnailRosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más

Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC


Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven

MarketWatch USA Business November 26, 2022

thumbnailRosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más

Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC


Pfizer CEO claims 400% price hike on COVID vaccines will be “free”

Ars Technica USA Science November 21, 2022

thumbnailNavigate Filter by topic Settings Front page layout Site theme - Nov 21, 2022 8:16 pm UTC / Pfizer CEO Albert Bourla talks during a press conference with the European Commission president after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the... + más

Moderna is suing Pfizer over its coronavirus vaccine | The Verge

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate


Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics

CNBC USA Health November 02, 2022

thumbnailPfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más

Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC

Pfizer climbs on strong Q3 results, raised outlook | MarketWatch


Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S.

Fox Business USA Business October 22, 2022

thumbnailFox News contributor Dr. Janette Nesheiwat discusses Pfizer’s new anti-viral COVID-19 pill and the importance of early treatment. has revealed the price it is eyeing in the U.S. for its adult COVID-19 vaccine on the commercial market. Ticker Security Last Change Change %... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Pfizer says COVID-19 vaccine will cost $110-$130 per dose | ABC News


Moderna sues Pfizer over patents behind COVID-19 vaccine

The Advocate USA Crime October 10, 2022

thumbnailvaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más

Moderna is suing Pfizer over its coronavirus vaccine | The Verge

Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times



About iurex | Privacy Policy | Disclaimer |